Concepedia

Shook Chin

SC

Statistics

Publications

2

Citations

96

H-Index

2

Active since

2022

Affiliations

Revolution Medicines (United States)(Current)

Shook Chin is an author at Revolution Medicines (United States) specializing in molecular oncology, kras inhibitors, and cancer cell signaling.

Publications per year

2022–2023

2

Publications

2

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRASG12D cancers

Lingyan Jiang, Marie Ménard, Caroline E. Weller et al. · Cancer Research · 2023 · 67 citations

, , +17

Abstract 3596: RM-036, a first-in-class, orally-bioavailable, Tri-Complex covalent KRASG12D(ON) inhibitor, drives profound anti-tumor activity in KRASG12D mutant tumor models

John E. Knox, Jingjing Jiang, G. Leslie Burnett et al. · Cancer Research · 2022 · 29 citations

, , +15

1–2 of 2